A Study to Evaluate Patient Experience and Satisfaction with Predictive Genomic Testing Ordered Through SL3

Overview

About this study

The purpose of this study is to better understand the impact of predictive genomic testing in the healthy adult population by assessing decisional satisfaction/regret, understanding of disease risk, lifestyle modifications, and satisfaction with the testing experience. 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Individuals who received results of predictive genomic testing through the SL3 clinic from 1/1/2017 to 6/30/2019.

Exclusion Criteria: 

  • Center for Individualized Medicine employees.
  • Non-English speaking patients.
  • Patients with no available email address.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Lazaridis, M.D.

Open for enrollment

Contact information:

Emily Lisi CGC, LCGC

Lisi.Emily@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20461789

Mayo Clinic Footer